廣州發展(600098.SH):截至目前,公司新能源裝機規模達到410萬千瓦
格隆匯6月25日丨廣州發展(600098.SH)在投資者關係活動上表示,截至目前,公司新能源裝機規模達到410萬千瓦。根據公司十四五規劃,新能源裝機規模將在十四五末達到800萬千瓦。公司正按照規劃穩步推進新能源項目投資建設,主要包括:(1)繼續圍繞全國五大“百萬基地”,綜合考慮消納及電價等因素,擇優選擇,有序推進風電、光伏發電重點項目建設及項目開發;(2)結合“百千萬工程”、“新能源+”等工作舉措,加強與當地政府及產業鏈上下游企業合作,推動新能源業務融合發展;(3)通過股權投資、基金等多種手段,豐富項目投資渠道;(4)積極探索抽水蓄能、儲能、氫能等領域項目開發和投資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.